Uday Baldota, VP- investor relations, Sun Pharma tells CNBC-TV18 that apart from the drug Taro‘s stellar contribution, other business segments also performed well
first published: May 30, 2012 05:04 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

